Powerful Senate committee invites pharma executives to testify
WASHINGTON (Reuters) – A powerful U.S. Senate committee on Monday invited seven...
Read MoreFeb 4, 2019
WASHINGTON (Reuters) – A powerful U.S. Senate committee on Monday invited seven...
Read MoreFeb 4, 2019
By Lisa Rapaport (Reuters Health) – Compounded pain creams are no better for chronic pain than topical treatments that contain no medicine at all, a U.S. study suggests. Compounded medicines are custom-blended by...
Read MoreFeb 4, 2019
By Yasmeen Abutaleb WASHINGTON (Reuters) – U.S. Senator Bernie Sanders sent a letter to...
Read MoreFeb 4, 2019
By Lisa Rapaport (Reuters Health) – Drivers who don’t wear seatbelts are more likely to skip seatbelts and car seats for their kids, an analysis of U.S. crash data suggests. When the driver in a crash wasn’t...
Read MoreFeb 4, 2019
By Carolyn Crist (Reuters Health) – Cancer patients are more successful at giving up cigarettes for good if they take smoking-cessation medicine for 24 weeks instead of the usual 12 weeks, a small clinical trial suggests....
Read MoreFeb 4, 2019
PARIS (Reuters) – Poland has reported a case of atypical bovine spongiform encephalopathy (BSE) among cattle on a farm near the Czech border, the Paris-based World Organisation for Animal Health (OIE) said on Monday. The...
Read MoreFeb 4, 2019
By Linda Carroll (Reuters Health) – Mirroring the decades-long increase in obesity rates in the U.S., cancers that are thought to be driven at least in part by excess weight are also on the rise among people under age 50,...
Read MoreFeb 4, 2019
(This Feb. 1 story has been corrected to remove reference to dosage in paragraph 7) By Manas...
Read MoreFeb 4, 2019
By Munkhchimeg Davaasharav ULAANBAATAR (Reuters) – Mongolia has extended school winter...
Read MoreFeb 2, 2019
By Keith Coffman DENVER (Reuters) – Denver voters will decide in May whether to decriminalize possession of small amounts of the hallucinogenic drug psilocybin, which would make it the first U.S. city to halt prosecution...
Read MoreFeb 1, 2019
By Lawrence Hurley WASHINGTON (Reuters) – The U.S. Supreme Court on Friday temporarily...
Read MoreFeb 1, 2019
By Caroline Humer NEW YORK (Reuters) – A top U.S. pharmacy benefit manager (PBM) owned by...
Read MoreFeb 1, 2019
(Reuters) – Pilgrim’s Pride Corp is recalling about 60,000 pounds of chicken products due to possible rubber contamination, a U.S. public health watchdog said on Friday, making it the third American meat producer in...
Read MoreFeb 1, 2019
(Reuters) – The U.S. Food and Drug Administration on Friday declined to approve Alkermes Plc’s opioid-based depression treatment, citing the need for additional data to prove the effectiveness of the drug. The...
Read MoreFeb 1, 2019
By Lisa Rapaport (Reuters Health) – When new mothers have friends ready to step in and help them, they have toddlers who score better on cognitive tests than the babies of women with smaller social support networks, a U.S....
Read MoreFeb 1, 2019
ZURICH (Reuters) – Novartis’s Kymriah cell therapy won the blessing of health...
Read MoreFeb 1, 2019
By Lisa Rapaport (Reuters Health) – A growing number of people in the U.S. are taking anti-anxiety drugs like Valium and Xanax not just for anxiety or depression but also for chronic pain, researchers say. These drugs are...
Read MoreFeb 1, 2019
By Linda Carroll (Reuters Health) – Among teens, using e-cigarettes may raise the risk of...
Read MoreFeb 1, 2019
By Carolyn Crist (Reuters Health) – When a teen is diagnosed with depression, it’s...
Read MoreFeb 1, 2019
BRUSSELS/WARSAW (Reuters) – The European Commission said on Friday it will send a team of...
Read More